The FDA did not violate the automatic stay by filing suit in District Court against the Debtor or by issuing a Press Release.  Court used its power under Section 105(a) to impose a temporary stay on the issuance of any future press releases or alerts by the FDA, subject to numerous conditions, but would not impose a stay of the District Court action.